Refreshing results…
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
UploadPARP inhibition enhances tumor cell–intrinsic immunity in ERCC1-deficient non–small cell lung cancer
Download from doi.orgCarboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
Download from www.nature.comHRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Download from www.nature.comMissing publications? Search for publications with a matching author name.